Skip to main content

Table 2 Multivariate analysis of clinical parameters influencing risk of cardiac adverse events

From: Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma

 

OR

95% CI

P-value

Prior history of cardiac events

 No

1

.045

 Yes

3.48

1.03–12.8

Use of antithrombotic agents

 No

1

.056

 Yes

3.66

0.97–8.79

Duration of PI therapy

1.94

1.21–3.09

.006

  1. Abbreviations: OR odds ratio, CI confidence interval, PI proteasome inhibitor